Integra Therapeutics

Overview
News
Human Gene Editing?
Product stageSegments
Seed
?
R&D therapies: CRISPR/Cas9 technology
?

Integra Therapeutics is a Spanish biotechnology company spun-out from the Pompeu Fabra University, specializing in CRISPR-based gene editing tools to accelerate the development of novel therapeutics. It uses its gene writing platform FiCAT, which addresses common concerns associated with gene therapy such as gene size, precision, and stability. The platform is applicable for both in vivo (gene editing done inside the body) and ex vivo (gene editing done in a specialized laboratory and returned to the body) therapies. It also uses CRISPR-Cas9 proteins and PiggyBac transposase to precisely engineer and insert DNA, reducing off-target occurrences. 

The company considers its ability to write large messages into genomes using its tech to be its edge. As fo June 2022, it had not disclosed its target indications and intended to work together with its funding investors on its plans going forward. 

Key customers and partnerships

In March 2023, Integra partnered with Predictive Oncology to advance gene therapy. Through the partnership, the companies would collaborate to help Integra Therapeutics to enhance the way it develops therapeutics for cancer.

Funding and financials

It raised EUR 6 million (USD 6.3 million) in its last seed round , which closed in March 2022 and was led by AdBio Partners, Invivo Capital, and Takeda Ventures. The funds were earmarked to further develop Integra’s platform and technologies.

HQ location:
Barcelona ESP
Founded year:
2020
Employees:
1-10
IPO status:
Private
Total funding:
USD 18.2 mn
Last Funding:
USD 2.7 mn (Grant; Jul 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.